Phase II trial of neoadjuvant cisplatin, gemcitabine, and bevacizumab followed by radical cystectomy (RC) in patients with muscle-invasive transitional cell carcinoma (TCC) of the bladder

被引：20
|
作者：
Chaudhary, U. B.
Golshayan, A. R.
Brisendine, A.
Kraft, A. S.
Clarke, H.
Keane, T. E.
机构：
[1] Calif State Univ Fresno, Fresno, CA 93740 USA
[2] Med Univ S Carolina, Charleston, SC 29425 USA
[3] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 07期
关键词：
D O I：
10.1200/jco.2011.29.7_suppl.276
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
276
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II trial of neoadjuvant nivolumab with cisplatin and gemcitabine in muscle-invasive bladder cancer patients undergoing radical cystectomy.
    Gupta, Shilpa
    Agarwal, Neeraj
    Konety, Badrinath R.
    Weight, Christopher J.
    Thyagarajan, Bharat
    Murugan, Paari J.
    Koopmeiners, Joseph S.
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [2] PHASE 2 TRIAL OF NEOADJUVANT GEMCITABINE AND CARBOPLATIN FOR MUSCLE-INVASIVE BLADDER CANCER FOLLOWED BY RADICAL CYSTECTOMY
    Koie, Takuya
    Okamoto, Teppei
    Imanishi, Kengo
    Sugiyama, Naoki
    Kudoh, Shigemasa
    Mori, Kazuyuki
    Tachiwada, Tokushi
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Kamimura, Noritaka
    Ohyama, Chikara
    Suzuki, Yuichiro
    JOURNAL OF UROLOGY, 2010, 183 (04): : E657 - E657
  • [3] Multicenter evaluation of neoadjuvant and induction gemcitabine–carboplatin versus gemcitabine–cisplatin followed by radical cystectomy for muscle-invasive bladder cancer
    Sarah M. H. Einerhand
    Anna J. Black
    Homayoun Zargar
    Adrian S. Fairey
    Colin P. Dinney
    Maria C. Mir
    Laura-Maria Krabbe
    Michael S. Cookson
    Niels-Erik Jacobson
    Jeffrey S. Montgomery
    Nikhil Vasdev
    Evan Y. Yu
    Evanguelos Xylinas
    Wassim Kassouf
    Marc A. Dall’Era
    Srikala S. Sridhar
    Jonathan S. McGrath
    Jonathan Aning
    Shahrokh F. Shariat
    Jonathan L. Wright
    Andrew C. Thorpe
    Todd M. Morgan
    Jeff M. Holzbeierlein
    Trinity J. Bivalacqua
    Scott North
    Daniel A. Barocas
    Yair Lotan
    Petros Grivas
    Jorge A. Garcia
    Andrew J. Stephenson
    Jay B. Shah
    Siamak Daneshmand
    Kamran Zargar-Shoshtari
    Philippe E. Spiess
    Bas W. G. van Rhijn
    Peter C. Black
    Laura S. Mertens
    World Journal of Urology, 2022, 40 : 2707 - 2715
  • [4] Phase II study of gemcitabine and split-dose cisplatin plus pembrolizumab as neoadjuvant therapy prior to radical cystectomy (RC) in patients with muscle-invasive bladder cancer (MIBC).
    Rose, Tracy L.
    Harrison, Michael Roger
    Deal, Allison Mary
    Osterman, Chelsea K.
    Ramalingam, Sundhar
    Whang, Young E.
    Brower, Blaine Y.
    Bjurlin, Marc
    Smith, Angela B.
    Nielsen, Matthew E.
    Tan, Hung-Jui
    Wallen, Eric M.
    George, Daniel J.
    Zhang, Tian
    Drier, Anthony
    Kim, William Y.
    Milowsky, Matthew, I
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [5] Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer
    Einerhand, Sarah M. H.
    Black, Anna J.
    Zargar, Homayoun
    Fairey, Adrian S.
    Dinney, Colin P.
    Mir, Maria C.
    Krabbe, Laura-Maria
    Cookson, Michael S.
    Jacobson, Niels-Erik
    Montgomery, Jeffrey S.
    Vasdev, Nikhil
    Yu, Evan Y.
    Xylinas, Evanguelos
    Kassouf, Wassim
    Dall'Era, Marc A.
    Sridhar, Srikala S.
    McGrath, Jonathan S.
    Aning, Jonathan
    Shariat, Shahrokh F.
    Wright, Jonathan L.
    Thorpe, Andrew C.
    Morgan, Todd M.
    Holzbeierlein, Jeff M.
    Bivalacqua, Trinity J.
    North, Scott
    Barocas, Daniel A.
    Lotan, Yair
    Grivas, Petros
    Garcia, Jorge A.
    Stephenson, Andrew J.
    Shah, Jay B.
    Daneshmand, Siamak
    Zargar-Shoshtari, Kamran
    Spiess, Philippe E.
    van Rhijn, Bas W. G.
    Black, Peter C.
    Mertens, Laura S.
    WORLD JOURNAL OF UROLOGY, 2022, 40 (11) : 2707 - 2715
  • [6] Neoadjuvant chemotherapy with gemcitabine plus carboplatin followed by immediate radical cystectomy for muscle-invasive bladder cancer
    Ohyama, Chikara
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Koie, Takuya
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (01) : 3 - 4
  • [7] A Single-arm Phase II Trial of Neoadjuvant Cabazitaxel and Cisplatin Chemotherapy for Muscle-Invasive Transitional Cell Carcinoma of the Urinary Bladder
    Challapalli, Amarnath
    Masson, Susan
    White, Paul
    Dailami, Narges
    Pearson, Sylvia
    Rowe, Edward
    Koupparis, Anthony
    Oxley, Jon
    Abdelaziz, Ahmed
    Ash-Miles, Janice
    Bravo, Alicia
    Foulstone, Emily
    Perks, Claire
    Holly, Jeff
    Persad, Raj
    Bahl, Amit
    CLINICAL GENITOURINARY CANCER, 2021, 19 (04) : 325 - 332
  • [8] A prospective phase II trial of neoadjuvant nivolumab plus gemcitabine/cisplatin chemotherapy in muscle-invasive urothelial carcinoma of bladder.
    Kim, Hongsik
    Kim, Ryul
    Hong, Joohyun
    Kwon, Ghee Young
    Kim, Chan Kyo
    Park, Won
    Song, Wan
    Sung, Hyun Hwan
    Jeong, Byong Chang
    Hong, Jung Yong
    Park, Se Hoon
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [9] Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder
    Sung, Hyun Hwan
    Kim, Hana
    Kim, Ryul
    Kim, Chan Kyo
    Kwon, Ghee Young
    Park, Won
    Song, Wan
    Jeong, Byong Chang
    Park, Se Hoon
    INVESTIGATIVE AND CLINICAL UROLOGY, 2022, 63 (02) : 168 - 174
  • [10] Neoadjuvant Therapy before radical Cystectomy for muscle-invasive Bladder Cancer Phase Ib/II Study for Evaluating the neoadjuvant Combination Therapy of Vinflunine with Cisplatin followed by a radical Cystectomy in Patients with muscle-invasive Bladder Cancer (JaNEO) - Study AB 50/15 of the AUO
    Rexer, H.
    Merseburger, A.
    UROLOGE, 2016, 55 (10): : 1366 - 1367
12345